Circle Pharma’s first-in-class orally bioavailable macrocyclic cyclin A/B inhibitors highlighted in poster presentations at American Association for Cancer Research Annual Meeting Epsilon09242023-07-19T07:02:31-07:00April 19, 2023|Press Releases|
